EGFR and glioblastoma: Due to the strong association between LANCL2/EGFR amplification and wild-type IDH1/2, univariate and multivariate analyses for survival was performed to investigate the prognostic values of LANCL2 and EGFR amplification in IDH1/2-wild-type GBM patients.